Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells.
about
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patientsThe role of NKT cells in tumor immunityStructural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory PropertiesNew ways to turn on NKT cellsThe differential expression of IL-4 and IL-13 and its impact on type-2 immunityStructure-function analysis of CCL28 in the development of post-viral asthma.ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival.PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivityAirway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivityNKT cells are necessary for maximal expression of allergic conjunctivitisIncreased Th2-like Invariant Natural Killer T cells in Peripheral Blood From Patients With Asthma.NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and InflammationGlycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.Invariant NKT cells are required for airway inflammation induced by environmental antigens.Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation.Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation.Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.Invariant Natural Killer T Cells Play a Role in Chemotaxis, Complement Activation and Mucus Production in a Mouse Model of Airway Hyperreactivity and Inflammation.Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal modelVaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice.Fluid-phase chain unsaturation controlling domain microstructure and phase in ternary lipid bilayers containing GalCer and cholesterolAirway hyperresponsiveness through synergy of gammadelta} T cells and NKT cells.Impact of sugar stereochemistry on natural killer T cell stimulation by bacterial glycolipids.Pneumocystis elicits a STAT6-dependent, strain-specific innate immune response and airway hyperresponsiveness.Repeated Activation of Lung Invariant NKT Cells Results in Chronic Obstructive Pulmonary Disease-Like Symptoms.Using house dust extracts to understand the immunostimulatory activities of living environmentsTLR4, 5, and 9 Agonists Inhibit Murine Airway Invariant Natural Killer T Cells in an IL-12-Dependent Manner.Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells.Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells.Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice.Immunogenetic programs for viral induction of mucous cell metaplasiaOzone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17The role of iNKT cells in development of bronchial asthma: a translational approach from animal models to human.Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung.A role for natural killer T cells in asthma.Flagellin Modulates the Function of Invariant NKT Cells From Patients With Asthma via Dendritic CellsEssential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation.Further marches: allergic and non-allergic.
P2860
Q21562196-0922D216-9B15-4168-BC72-440EC3EBCB5BQ24648939-DDB5EC70-A2FD-482F-9927-07505900051FQ27677017-02E7E11D-46DD-4715-B0E0-77E734A6AF61Q27693911-753346BE-822B-4C97-B274-1C3C3D810110Q28083968-C884B0F9-2A74-47C3-9A2D-3A02AA1D1425Q30370396-832293D9-4820-4415-BFE1-6F0FA5E32FEFQ33715268-70E307FC-8D2F-4C70-A2B8-7F980AE92616Q33753894-C6A53B29-D678-4D74-80BF-60BB93DA05A6Q33753900-E5174E26-EB87-4426-8905-B9D777B4C285Q33782854-2405D943-7773-4C87-AD01-6A387475E348Q33836325-0CF6AD1C-3908-4874-BDE2-4508055322EBQ34013551-8DA88BD1-A9F3-4756-9067-95C734768245Q34167933-033FCA79-A0E4-4666-91D0-D91A4F02F7AAQ34288977-89041795-1E7A-4A97-ABB5-515A4F94BE4CQ34983932-41D23B59-84BE-482D-AE9A-EB1E17B66762Q35213600-AC40137E-F7A7-486C-B005-C701F7360457Q35237482-5AB88624-7E01-4C93-848F-5521C7B6AE34Q35403571-93C8B892-CBD5-4699-BCCB-393213D8185EQ35634065-DDD51658-C946-4180-94E2-B80267A3458EQ35661750-0B7A7A72-CCA6-4AEA-86D9-0432B5D3040FQ35670019-5C1670B1-F213-4D9C-8EEA-81EF8B61FB43Q35679658-B5FA12A5-683F-4522-9B1A-1473749293B1Q35696533-FD194D09-EC8E-46D6-AB02-5AEBA14CF479Q35781960-D13FA728-F0AE-4D14-B965-A856EA044908Q35841349-C42420A2-059D-418E-AFA0-2D8280AB6D1EQ35889172-390F1AF1-3FB5-4037-8AE2-13B890C37C6FQ35904768-51C060D3-E475-4846-9242-69BB19463119Q35946633-C13FAC3F-FCB9-4A4E-BA7A-2710EF4C0937Q36177350-CBAC2427-8D07-48F5-B408-80DA71282E58Q36229067-2B5211F2-7835-4398-90FF-F03BF4A68476Q36280211-0AF65166-F679-4E2C-9FF5-D5B1B1CFC91BQ36365809-3018ED1A-DE87-4A9E-8AEC-82C6735702BEQ36423688-F72E8B94-CC25-44D6-A971-5CC95722863AQ36502818-7C5A0AFF-B0BA-4F8F-AF5A-7B71D7D1EEC2Q36546611-788D9A6C-6DB0-46D8-A3B6-CBF01C21B0B8Q36598607-47782694-FB79-4DCC-A168-9D1B14476C28Q36636149-9861B149-7BD0-4C40-B1D2-35DF8509BF85Q36636574-BFA83462-E553-4977-AE63-316C4F65C37CQ36639967-BC07C1A0-1548-4A4F-8081-3180BC4EFB9FQ36789966-1F6F8895-4B6A-4E65-9A8B-EA6B6FE372E5
P2860
Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@ast
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@en
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@nl
type
label
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@ast
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@en
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@nl
prefLabel
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@ast
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@en
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@nl
P2093
P2860
P356
P1476
Glycolipid activation of invar ...... of conventional CD4+ T cells.
@en
P2093
Dale T Umetsu
Everett H Meyer
Gerald J Berry
Omid Akbari
Paul B Savage
Rosemarie H DeKruyff
Toshinori Nakayama
P2860
P304
P356
10.1073/PNAS.0510282103
P407
P577
2006-02-14T00:00:00Z